Date: 27th April 2021
Time: from 9:00 PM to 10:00 PM
Audience: Veterinarians and Nurses - Companion Segment
Price: AED 0
Dr. Richard Ford
A graduate of Ohio State University, Dr. Ford practiced small animal and equine medicine prior to completing the internal medicine residency at Michigan State University. He taught internal medicine at Purdue University and North Carolina State University. He is Board Certified by the American College of Veterinary Internal Medicine and is an honorary Diplomate in the American College of Veterinary Preventive Medicine. Dr. Ford is the Lead Editor of the AAHA Canine Vaccine Guidelines and a co-author on the AAFP Feline Vaccine Guidelines.
In this webinar Dr. Richard B. Ford addresses the practical aspects of antibody testing for vaccine-preventable disease in clinical practice.
As “vaccine hesitancy” impacts veterinary medicine, the utilization of “Vaccine Titers” (Antibody testing for Vaccine-Preventable Diseases) has growing relevance in companion animal practice.
The recent introduction of valid, Point-of-Care Tests kits provides clinicians the opportunity to objectively assess the need for, and response to, core vaccines…and do so within minutes.
This presentation addresses the 3 most fundamental issues facing veterinarians regarding application of antibody testing in practice:
- are test results a valid indication of protective immunity?
- if so, what are the indications for testing individual patients?
- how do test results (“positive” vs “negative”) impact patient management decisions?
At Eurovets, we represent leading multi-national brands in nutrition, veterinary equipment, medicines and consumables for companion-, equine and production animals. In addition to traditional wholesale, Eurovets provides warehousing, distribution, CPD training, webinars, marketing and sales resources in order to support these products in the region.
Eurovets is excited to have Dr. Ford conducting this webinar and share her knowledge and broad experience with our Companion customers here in the UAE.